From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Native name
天士力控股集团 (Tiānshìlì Kònggǔ Jítuán)
IndustryPharmaceutical industry

Tasly (Chinese: 天士力控股集团; pinyin: Tiānshìlì Kònggǔ Jítuán) is a Chinese pharmaceutical company based in the city of Tianjin.[1] It was established in 1994 and is notably producing traditional Chinese medicines.[1]

It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.[2]

In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.[3]

In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife.[4]

See also[edit]

Notes and references[edit]

  1. ^ a b About Tasly Archived 16 July 2015 at archive.today (page visited on 29 May 2015).
  2. ^ (in French) Dejan Nikolic, "L’une des trois plus grosses pharmas chinoises s’installe à Genève", Le Temps, 29 May 2015 (page visited on 29 May 2015).
  3. ^ "院士李连达与天士力论战背后:或与广药存利益关系". Sina Finance. 21 September 2014. Retrieved 23 October 2018.
  4. ^ "Herbalife Ltd. Reaches Agreement in Principle to Form Joint Venture with China's Tasly Holding Group". BusinessWire.com. Retrieved 23 February 2017.

External links[edit]